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Background
CD8+ T cell responses play a critical role in the early con-
trol of HIV. The identification of rapidly evolving sites in
HIV provides a powerful means of identifying which CD8
responses are exerting strong immune pressure on the
virus and may thus be driving early viral containment.
Here we applied next generation sequencing technologies
to accurately characterize viral evolution during acute HIV
infection at high sensitivity across the complete viral
genome.
Methods
Four overlapping ~3 kb amplicons spanning the HIV
genome were PCR amplified from the plasma of six sub-
jects at multiple time points during the first six months of
infection. The amplicons were molecularly bar-coded,
pooled, and sequenced by 454 to yield over 60 million
base pairs of data, resulting in ~250-fold coverage and a
sensitivity to detect minor variants down to 1%. A subset
of amplicons was also sequenced by Illumina at ~8000-
fold coverage.
Results
454 sequencing revealed numerous rapidly evolving sites
distributed across the viral genome with a majority
located in the accessory genes, and numerous mutations
consistent with reversion of transmitted mutations to con-
sensus sequence. When viral escape was observed, it was
often highly complex, involving evolution at multiple
positions and/or expression of multiple non-consensus
residues. In some epitopes, initial CTL escape mutations
reverted and were rapidly replaced by mutations at other
residues within the epitope, suggesting competition
between multiple escape variants for dominance over
time. In several cases, the frequency of likely compensa-
tory mutations, e.g., non-epitopic mutations, was
observed to track almost perfectly over time with escape
mutations, evidence of linkage of residues on viral haplo-
types.
Conclusion
These data illustrate the value of next generation sequenc-
ing for the rapid, sensitive, and comprehensive identifica-
tion of early HIV escape and reversion and for the
characterization of epitopes under substantial early CTL
pressure, a proxy for effective anti-viral CD8+ T cell activ-
ity.
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